Objective To provide recommendations for the management of juvenile idiopathic arthritis
(JIA) with a focus on nonpharmacologic therapies, medication monitoring, immunizations …

The use of multiple medications is growing at an alarming rate with some reports
documenting an average of 12–22 prescriptions being used by individuals≥ 50 years of …

Importance Parents of children with severe neurological impairment (SNI) manage complex
medication regimens (CMRs) at home, and clinicians can help support parents and simplify …

Introduction: Polypharmacy is a risk factor for adverse health outcomes, higher use of
medical services and additional costs. The problem has gained attention as a consequence …

Background Children with medical complexity (CMC) are a priority pediatric population, with
high resource use and associated costs. Genome-wide sequencing is increasingly …

In pediatric individuals, polypharmacy would increase the prevalence of adverse drug
reactions (ADRs). However, there is no report on the ADR increase adjusted for the …

Background The use of antipsychotic medication and psychotropic polypharmacy has
increased in the United States over the last two decades especially for children from low …

Translational paediatric drug development includes the exchange between basic, clinical
and population-based research to improve the health of children. This includes the …

Background International data and guidance on prescribing for children and young people
with autism spectrum disorder (ASD) are limited. National administrative datasets such as …

Background As survivors of childhood cancer age, development of cancer treatment-related
chronic health conditions often occur. This study aimed to describe the pattern of chronic …